Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Sanofi (SNY) Equity Ratio (2016 - 2018)

Historic Equity Ratio for Sanofi (SNY) over the last 17 years, with Q2 2025 value amounting to 0.56.

  • Sanofi's Equity Ratio fell 2.83% to 0.56 in Q2 2025 from the same period last year, while for Jun 2025 it was 0.56, marking a year-over-year decrease of 2.83%. This contributed to the annual value of 0.59 for FY2024, which is 13.98% up from last year.
  • Per Sanofi's latest filing, its Equity Ratio stood at 0.56 for Q2 2025, which was down 2.83% from 0.59 recorded in Q4 2024.
  • Sanofi's 5-year Equity Ratio high stood at 0.59 for Q4 2022, and its period low was 0.02 during Q2 2021.
  • Its 5-year average for Equity Ratio is 0.52, with a median of 0.58 in 2023.
  • In the last 5 years, Sanofi's Equity Ratio crashed by 9855.09% in 2021 and then skyrocketed by 250669.24% in 2022.
  • Over the past 5 years, Sanofi's Equity Ratio (Quarter) stood at 0.57 in 2021, then increased by 3.32% to 0.59 in 2022, then dropped by 0.79% to 0.59 in 2023, then increased by 0.14% to 0.59 in 2024, then dropped by 4.07% to 0.56 in 2025.
  • Its Equity Ratio stands at 0.56 for Q2 2025, versus 0.59 for Q4 2024 and 0.56 for Q2 2024.